The Native Antigen Company

Address

Building B, Langford Locks
Kidlington
Oxford, OX5 1LH
United Kingdom

Phone: +44 1865 595 230

Visit Website Request Information/Quote Download PDF Copy

Recent Tweets

The WHO last week announced its #vaccine recommendations for the 2022/2023 Northern Hemisphere #flu season. The Na… https://t.co/UeDmPWGdPi

Mar 2 2022 5:57am
In this editorial for @biocompare, we comment on the role of reagents in assessing the efficacy of vaccines, and th… https://t.co/7IlxmjqIbB

Feb 23 2022 3:52am
RT @EBRmagazine: James Shore at @nativeantigen explores the challenges of flaviviruses and the urgent need for more accurate data. Read th…

Feb 17 2022 11:57am

At the Native Antigen Company we are experts in the development and manufacturing of infectious disease antigens from bacteria and viruses, and in the production of recombinant forms of these antigens using our proprietary mammalian expression system.

These antigens are prepared for both research and development purposes, and also on bulk scale for IVD manufacturers to incorporate into their immunoassays.

Our R&D team have particular expertise in flavivirus biology. We were the first in the world to develop mammalian expressed Dengue virus NS1 antigens, and then to develop Zika virus NS1 using the same platform. We have also developed a range of Virus-like particles, which are finding increasing applications as antigens for IVD applications.

We continue to develop cutting edge antigens, and are also now using these antigens to raise highly specific monoclonal antibodies and to develop immunoassays. We also offer these services on a contract basis for customers who need a reliable source of high quality recombinant or native protein.